TR
EN
Acute phase reaction with zoledronic acid infusion mimicking COVID-19
Öz
During the pandemic, symptoms of many diseases that can be confused with the symptoms of COVID-19 have been detected and reported. In this case report, we reported a patient who showed flu-like symptoms and sudden lymphopenia within two days of zoledronic acid infusion. A 40-year-old female patient with a COVID-19 history was admitted to our hospital with abdominal pain. Hypercalcemia due to parathyroid adenoma was detected. Zoledronic acid (5 mg) was given intravenously for the treatment of hypercalcemia. Following the infusion, fever, C-Reactive Protein (CRP) increase and lymphopenia were detected in the patient. There were no apparent causes to explain these symptoms. The side effects we detected in the patient were confusingly similar to the symptoms of COVID-19. Repeated PCR tests and CT results indicated that the patient did not have COVID-19. A week later, the patient’s symptoms improved and the laboratory findings along with the physical examination returned to normal. The patient's condition was considered to be due to zoledronic acid infusion. We would like to draw attention to the acute phase reaction after zoledronic acid infusion in the COVID-19 era in which the clinical situation could be confusing.
Anahtar Kelimeler
Kaynakça
- Leere JS, Karmisholt J, Robaczyk M, Vestergaard P. Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review. Front Endocrinol (Lausanne). 2017 Apr 20;8.
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020 Feb;395(10223):497–506.
- Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020 Mar;34:101623.
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 Mar; 395(10229):1054–62.
- Coleman R, Burkinshaw R, Winter M, Neville-Webbe H, Lester J, Woodward E, et al. Zoledronic acid. Expert Opin Drug Saf. 2011 Jan 29;10(1):133–45.
- Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, et al. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis. New England Journal of Medicine. 2007 May 3;356(18):1809– 22.
- Boonen S, Black DM, Colón-Emeric CS, Eastell R, Magaziner JS, Eriksen EF, et al. Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older. J Am Geriatr Soc. 2010 Feb;58(2):292–9.
- Schweitzer DH, Oostendorp-van de Ruit M, van der Pluijm G, Löwik CWGM, Papapoulos SE. Interleukin-6 and the acute phase response during treatment of patients with paget’s disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate. Journal of Bone and Mineral Research. 2009 Dec 3;10(6):956–62.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Endokrinoloji
Bölüm
Olgu Sunumu
Yayımlanma Tarihi
18 Eylül 2023
Gönderilme Tarihi
4 Ekim 2022
Kabul Tarihi
26 Nisan 2023
Yayımlandığı Sayı
Yıl 2023 Cilt: 62 Sayı: 3
APA
Koygun, Ö. D., Kurşunoğlu, N. E., Özışık, H., Saygılı, F., & Sarer Yürekli, B. (2023). Acute phase reaction with zoledronic acid infusion mimicking COVID-19. Ege Tıp Dergisi, 62(3), 473-476. https://doi.org/10.19161/etd.1360346
AMA
1.Koygun ÖD, Kurşunoğlu NE, Özışık H, Saygılı F, Sarer Yürekli B. Acute phase reaction with zoledronic acid infusion mimicking COVID-19. ETD. 2023;62(3):473-476. doi:10.19161/etd.1360346
Chicago
Koygun, Öyküm Deniz, Niyazi Emre Kurşunoğlu, Hatice Özışık, Füsun Saygılı, ve Banu Sarer Yürekli. 2023. “Acute phase reaction with zoledronic acid infusion mimicking COVID-19”. Ege Tıp Dergisi 62 (3): 473-76. https://doi.org/10.19161/etd.1360346.
EndNote
Koygun ÖD, Kurşunoğlu NE, Özışık H, Saygılı F, Sarer Yürekli B (01 Eylül 2023) Acute phase reaction with zoledronic acid infusion mimicking COVID-19. Ege Tıp Dergisi 62 3 473–476.
IEEE
[1]Ö. D. Koygun, N. E. Kurşunoğlu, H. Özışık, F. Saygılı, ve B. Sarer Yürekli, “Acute phase reaction with zoledronic acid infusion mimicking COVID-19”, ETD, c. 62, sy 3, ss. 473–476, Eyl. 2023, doi: 10.19161/etd.1360346.
ISNAD
Koygun, Öyküm Deniz - Kurşunoğlu, Niyazi Emre - Özışık, Hatice - Saygılı, Füsun - Sarer Yürekli, Banu. “Acute phase reaction with zoledronic acid infusion mimicking COVID-19”. Ege Tıp Dergisi 62/3 (01 Eylül 2023): 473-476. https://doi.org/10.19161/etd.1360346.
JAMA
1.Koygun ÖD, Kurşunoğlu NE, Özışık H, Saygılı F, Sarer Yürekli B. Acute phase reaction with zoledronic acid infusion mimicking COVID-19. ETD. 2023;62:473–476.
MLA
Koygun, Öyküm Deniz, vd. “Acute phase reaction with zoledronic acid infusion mimicking COVID-19”. Ege Tıp Dergisi, c. 62, sy 3, Eylül 2023, ss. 473-6, doi:10.19161/etd.1360346.
Vancouver
1.Öyküm Deniz Koygun, Niyazi Emre Kurşunoğlu, Hatice Özışık, Füsun Saygılı, Banu Sarer Yürekli. Acute phase reaction with zoledronic acid infusion mimicking COVID-19. ETD. 01 Eylül 2023;62(3):473-6. doi:10.19161/etd.1360346